Why the study?
Is the metabolically healthy obese phenotype associated with an excess burden of clinical CVD, and can hs-cTnT stratify this risk?
Is the metabolically healthy obese phenotype associated with an excess burden of clinical CVD, and can hs-cTnT stratify this risk?
Metabolically healthy obesity is not a benign condition and carries an excess risk of cardiovascular disease, particularly heart failure, which can be further risk-stratified using hs-cTnT.
Answers are grounded in this paper and cite their sources.
May warrant closer HF monitoring in metabolically healthy obesity; hypothesis-generating for hs-cTnT stratification.
The metabolically healthy obese phenotype was associated with excess burden of clinical CVD, primarily driven by an excess risk of HF. hs-cTnT was useful in stratifying CVD risk across all obesity phenotypes, even among obese individuals who appear otherwise metabolically healthy.
No takes yet. Share an insight, caveat, or question.
Commodore‐Mensah et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: